A substantial advancement in diabetes management is emerging with the introduction of tirzepatide at a dosage of 45mg. This new version builds upon the existing success of tirzepatide, a dual GIP and GLP-1 receptor, https://albertdgxh507708.wikistatement.com/5603630/significant_development_tirzepatide_45mg_for_blood_sugar_regulation